102 related articles for article (PubMed ID: 24901151)
1. Resveratrol inhibits VEGF gene expression and proliferation of hepatocarcinoma cells.
Zhang H; Yang R
Hepatogastroenterology; 2014; 61(130):410-2. PubMed ID: 24901151
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of resveratrol on the expression of the VEGF gene and proliferation in renal cancer cells.
Yang R; Zhang H; Zhu L
Mol Med Rep; 2011; 4(5):981-3. PubMed ID: 21687947
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol inhibits VEGF expression of human hepatocellular carcinoma cells through a NF-kappa B-mediated mechanism.
Yu HB; Zhang HF; Zhang X; Li DY; Xue HZ; Pan CE; Zhao SH
Hepatogastroenterology; 2010; 57(102-103):1241-6. PubMed ID: 21410066
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol suppresses the STAT3 signaling pathway and inhibits proliferation of high glucose-exposed HepG2 cells partly through SIRT1.
Li Y; Zhu W; Li J; Liu M; Wei M
Oncol Rep; 2013 Dec; 30(6):2820-8. PubMed ID: 24064760
[TBL] [Abstract][Full Text] [Related]
5. Pro-apoptotic and anticancer properties of Thapring - A Tibetan herbal formulation.
Choedon T; Dolma D; Kumar V
J Ethnopharmacol; 2011 Sep; 137(1):320-6. PubMed ID: 21658439
[TBL] [Abstract][Full Text] [Related]
6. The novel resveratrol derivative 3,5-diethoxy-3',4'-dihydroxy-trans-stilbene induces mitochondrial ROS-mediated ER stress and cell death in human hepatoma cells in vitro.
Park JW; Choi WG; Lee PJ; Chung SW; Kim BS; Chung HT; Cho S; Kim JH; Kang BH; Kim H; Kim HP; Back SH
Acta Pharmacol Sin; 2017 Nov; 38(11):1486-1500. PubMed ID: 28795692
[TBL] [Abstract][Full Text] [Related]
7. A comparative assessment of antiproliferative properties of resveratrol and ethanol leaf extract of Anogeissus leiocarpus (DC) Guill and Perr against HepG2 hepatocarcinoma cells.
Olugbami JO; Damoiseaux R; France B; Onibiyo EM; Gbadegesin MA; Sharma S; Gimzewski JK; Odunola OA
BMC Complement Altern Med; 2017 Aug; 17(1):381. PubMed ID: 28768515
[TBL] [Abstract][Full Text] [Related]
8. Antimyeloma effects of resveratrol through inhibition of angiogenesis.
Hu Y; Sun CY; Huang J; Hong L; Zhang L; Chu ZB
Chin Med J (Engl); 2007 Oct; 120(19):1672-7. PubMed ID: 17935668
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol inhibits tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells.
Yu H; Pan C; Zhao S; Wang Z; Zhang H; Wu W
Biomed Pharmacother; 2008; 62(6):366-72. PubMed ID: 17988825
[TBL] [Abstract][Full Text] [Related]
10. The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis.
Wang F; He Z; Dai W; Li Q; Liu X; Zhang Z; Zhai D; Chen J; Chen W
J Cancer Res Ther; 2015; 11(3):597-605. PubMed ID: 26458588
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells.
Jiang Q; Yang M; Qu Z; Zhou J; Zhang Q
BMC Complement Altern Med; 2017 Oct; 17(1):477. PubMed ID: 28978315
[TBL] [Abstract][Full Text] [Related]
12. Emodin inhibits the growth of hepatoma cells: finding the common anti-cancer pathway using Huh7, Hep3B, and HepG2 cells.
Hsu CM; Hsu YA; Tsai Y; Shieh FK; Huang SH; Wan L; Tsai FJ
Biochem Biophys Res Commun; 2010 Feb; 392(4):473-8. PubMed ID: 19895793
[TBL] [Abstract][Full Text] [Related]
13. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell.
Liu X; Yang Y; Zhang X; Xu S; He S; Huang W; Roberts MS
J Gastroenterol Hepatol; 2010 Feb; 25(2):420-6. PubMed ID: 19793165
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells.
Zhang C; Liu L; Yu Y; Chen B; Tang C; Li X
Mol Med Rep; 2012 May; 5(5):1295-8. PubMed ID: 22366885
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation.
Notas G; Nifli AP; Kampa M; Vercauteren J; Kouroumalis E; Castanas E
Biochim Biophys Acta; 2006 Nov; 1760(11):1657-66. PubMed ID: 17052855
[TBL] [Abstract][Full Text] [Related]
16. trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells.
Cao Z; Fang J; Xia C; Shi X; Jiang BH
Clin Cancer Res; 2004 Aug; 10(15):5253-63. PubMed ID: 15297429
[TBL] [Abstract][Full Text] [Related]
17. Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns.
Cai J; Zhao XL; Liu AW; Nian H; Zhang SH
Phytomedicine; 2011 Mar; 18(5):366-73. PubMed ID: 20850954
[TBL] [Abstract][Full Text] [Related]
18. Berberine inhibits angiogenic potential of Hep G2 cell line through VEGF down-regulation in vitro.
Jie S; Li H; Tian Y; Guo D; Zhu J; Gao S; Jiang L
J Gastroenterol Hepatol; 2011 Jan; 26(1):179-85. PubMed ID: 21175812
[TBL] [Abstract][Full Text] [Related]
19. [Effects of resveratrol on apoptosis and ROS production in Hepa 1-6 hepatocarcinoma cells].
Du Q; Shen KP; Hu B; Deng S
Zhong Yao Cai; 2012 Mar; 35(3):443-8. PubMed ID: 22876687
[TBL] [Abstract][Full Text] [Related]
20. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
